Liver Diseases
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (12)
Total enrollment: 2,006 patients across 12 trials
A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial
A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems
A Research Study on Etavopivat in Participants With and Without Liver Disease
A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function
A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.
A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.
A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems
Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib
RESTORE Declined Livers Study
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B